| Home Market Dynamics You and Market Sector Analysis Company Insights AI Investing About Contact Us Login |
| The price action of Health Care (XLV) sector is shaped by numerous forces, ranging from broad macroeconomic trends to company-specific performance and market structure. The overall sentiment for Health Care sector is very positive (overall 2.8, positive 3.3, negative -0.5) on 20251024. The forces of Sentiment towards Fundamentals (2.2), Price Level (2), Option Speculation (1.5), Broad Market Trend (0.4), Sector Price Trend (0.4), and Valuation Sentiment (-1) will drive up the price. The forces of and Market Risk Prefrence (0) will drive down the price. 'Buy the dips' is the preferred trading strategy. Hourly SMA 20 trend line is likely to provide a support from any pullbacks. The swing to upside will be significant considering the high positive sentiment forces (3.3). The extreme bullish overall sentiment (2.8) may signal the top of this uptrend. The sentiment for Broad Market Trend is calculated based on SPY trend. The sentiment for Sector Price Trend is calculated based on XLV trend. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Prefrence is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. |
| Date | Attention | Average Attention | Price | Price Level | Change | SMA10 Trend | Market Sentiment | Trend Sentiment | Fundamentals | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-24 | 1% | 0.9% | 146.05 | 79 | 0.01% | 0.28% | 1.4 | 0.4 | 2.2 | 0.9 |
| 2025-10-23 | 1% | 1% | 146.04 | 79 | 0.02% | 0.07% | 1.5 | 0.7 | 2.3 | 3.7 |
| 2025-10-22 | 1% | 1% | 146 | 79 | 0.65% | 0.14% | 1.3 | 0.7 | 2.3 | 1.2 |
| 2025-10-21 | 2% | 1.1% | 145.06 | 75 | 0.21% | 0.07% | 1.5 | 0.6 | 2.4 | 4.4 |
| 2025-10-20 | 1% | 1.1% | 144.76 | 75 | 1.06% | 0% | 1.3 | 0.5 | 2.5 | 6.3 |
| 2025-10-19 | 0% | 1% | 1.5 | 0 | 2.5 | 0 | ||||
| 2025-10-18 | 0% | 1.1% | 1.5 | 0 | 2.5 | 8 | ||||
| 2025-10-17 | 2% | 1.3% | 143.24 | 67 | 0.64% | -0.07% | 1.3 | 0 | 2.2 | 2.7 |
| 2025-10-16 | 1% | 1.1% | 142.33 | 62 | -0.17% | -0.07% | 0.7 | -0.2 | 2.2 | 4 |
| 2025-10-15 | 2% | 1% | 142.57 | 66 | 0.17% | -0.07% | 0.8 | -0.3 | 2.2 | 4 |
| Both emotion scores and sentiment scores are calculated in a -10 - +10 scale. | The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| 1 (-7) Obamacare premiums set to surge 30% as subsidy support falls away Biggest premiums in Affordable Care Act EVER on the cards. (https://www.investmentnews.com/) Fri. Oct 24, 2025 | |
| 2 (8) UnitedHealth's Moment of Truth: 3 Bullish Signals to Watch For UnitedHealth's Q3 earnings are set to prove its recovery is real, validating the stock's recent rally and confirming its turnaround strategy is on track. (https://www.marketbeat.com/) Fri. Oct 24, 2025 | |
| 3 (-6) CVS To Close 16 Oak Street Health Centers Amid Industry Cost Issues CVS Health is shuttering 16 Oak Street Health Centers, or 7% of the total number of the senior-focused primary care locations the company operates in the U.S. (https://www.forbes.com/) Fri. Oct 24, 2025 | |
| 4 (8) Bayer Wins FDA Approval for Menopause Drug Treating Hot Flashes Bayer AG won support from US regulators for a menopause drug that’s expected to hit the market in November under the name of Lynkuet. (https://www.bloomberg.com/) Fri. Oct 24, 2025 | |
| 5 (-2) Why Is Syndax Stock Down Today? Shares of Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) are trading lower Friday following approval of one of its treatments from the U.S.'s Food and Drug Administration. (https://www.benzinga.com/) Fri. Oct 24, 2025 | |
| 6 (-8) Paying too much for health insurance? Get ready to pay even more. Whether you’re on an employer-based plan or receive coverage through the Affordable Care Act marketplace, health insurance premiums are on track to rise in a big way in 2026. (https://finance.yahoo.com/) Fri. Oct 24, 2025 | |
| 7 (8) This medical technology firm has a "best-in-class portfolio," UBS says This medical technology firm has a "best-in-class portfolio," UBS says (https://www.investing.com/) Fri. Oct 24, 2025 | |
| 8 (-7) Paying too much for health insurance? Get ready to pay even more. Whether you’re on an employer-based plan or receive coverage through the Affordable Care Act marketplace, health insurance premiums are on track to rise in a big way in 2026. (https://finance.yahoo.com/) Fri. Oct 24, 2025 | |
| 9 (8) Dupixent Pushes Sanofi's Quarterly Sales Past $14.5 Billion Mark Sanofi Q3 sales beat estimates on strong Dupixent and new drug demand; reaffirms 2025 outlook with double-digit EPS growth expected. (https://www.benzinga.com/) Fri. Oct 24, 2025 | |
| 10 (7) Eli Lilly to buy Adverum, General Dynamics stock hits new record Market Catalysts host Julie Hyman tracks several of the day's top trending stock tickers, including Eli Lilly's (LLY) deal to acquire Adverum Biotechnologies (ADVM), gold miner Newmont's (NEM) cost-cutting initiatives, and General Dynamics (GD) shares moving to an all-time record high following its latest earnings results fueled by jet demand. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts. (https://finance.yahoo.com/) Fri. Oct 24, 2025 | |
| 11 (8) Boston Scientific Delivers Robust Q3 Despite Tariff Headwinds: Analyst Boston Scientific posts $5.07 billion in Q3 revenue, beats earnings estimates, sees WATCHMAN growth at 35%, and raises 2025 sales forecast. (https://www.benzinga.com/) Thu. Oct 23, 2025 | |
| 12 (7) What To Expect When HCA Healthcare Reports Q3 Earnings On Friday HCA Healthcare Q3 earnings eyed at $5.72 per share, backed by patient growth, DPP contributions, and favorable payor trends. (https://www.benzinga.com/) Thu. Oct 23, 2025 | |
| 13 (9) West Pharma Soars After Q3 Beat, Lifts Outlook On GLP-1 Demand West Pharmaceutical posts Q3 earnings of $1.96 per share and raises 2025 guidance, driven by GLP-1 demand and strong HVP component growth. (https://www.benzinga.com/) Thu. Oct 23, 2025 | |
| 14 (-7) This health insurer’s stock tumbles again as Medicaid, Obamacare businesses worsen Molina Healthcare’s stock was tumbling after a big profit miss, as medical costs keep rising because more people are making insurance claims. (https://www.marketwatch.com/) Thu. Oct 23, 2025 | |
| 15 (-6) UnitedHealth’s Optum Unit Gets Second New CFO in Six Months The finance leader at one of UnitedHealth Group Inc.’s two major divisions has left that role after less than six months, the latest sign of rapid turnover in the top ranks of the health insurance conglomerate as it tries to recover from a series of crises that have jolted investors’ confidence. (https://www.bloomberg.com/) Thu. Oct 23, 2025 | |
| 16 (7) Micro-Doses of $200,000 Cancer Drugs Help Patients for Less Hi, it’s Bob in New York, along with Ashleigh in Germany. Studies are hinting that lower doses of immune therapy drugs may help patients and save money. But first ... (https://www.bloomberg.com/) Thu. Oct 23, 2025 | |
| 17 (7) EXCLUSIVE: Trinity Capital's New Loan Fuels Bobbie's Mission To Set New US Infant Nutrition Standards Trinity Capital Inc. announced a financing agreement with Bobbie, an organic infant nutrition company, to boost production capacity and ensure wider distribution of its products. (https://www.benzinga.com/) Thu. Oct 23, 2025 | |
| 18 (8) Google claims ‘quantum advantage’ that promises drug discovery breakthroughs Google claimed to have gained an edge in the race to demonstrate the first practical use of a quantum computer, revealing an algorithm that it... (https://finance.yahoo.com/) Thu. Oct 23, 2025 | |
| 19 (0) Sanofi’s third-quarter results seen steady as margin outlook draws focus Sanofi’s third-quarter results seen steady as margin outlook draws focus (https://www.investing.com/) Thu. Oct 23, 2025 | |
About
Contact Us
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA